nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced non-invasive diagnostic techniques for visualization and estimation of kidney fibrosis
|
Srivastava, Anjali |
|
|
26 |
8 |
p. 2053-2063 |
artikel |
2 |
Coming of age of Allotrope: Proceedings from the Fall 2020 Allotrope Connect
|
Millecam, Todd |
|
|
26 |
8 |
p. 1922-1928 |
artikel |
3 |
Computational insights into the known inhibitors of human soluble epoxide hydrolase
|
Bzówka, Maria |
|
|
26 |
8 |
p. 1914-1921 |
artikel |
4 |
Construction of cancer-on-a-chip for drug screening
|
Liu, Yan |
|
|
26 |
8 |
p. 1875-1890 |
artikel |
5 |
Contents page 1
|
|
|
|
26 |
8 |
p. i |
artikel |
6 |
Contents page 2
|
|
|
|
26 |
8 |
p. ii-iii |
artikel |
7 |
Corrigendum to “An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles” [Drug Discov. Today 25 (2020) 505–518]
|
Kalaria, Dhaval R. |
|
|
26 |
8 |
p. 2076 |
artikel |
8 |
Corrigendum to “NCp7: targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders” [Drug Discov. Today 23(2018) 687–695]
|
Iraci, Nunzio |
|
|
26 |
8 |
p. 2075 |
artikel |
9 |
Corrigendum to ‘Synthetic lethality: a step forward for personalized medicine in cancer’ [Drug Discov. Today 25 (2020) 305–320]
|
Jariyal, Heena |
|
|
26 |
8 |
p. 2077 |
artikel |
10 |
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
|
Ho, Gilbert |
|
|
26 |
8 |
p. 2036-2044 |
artikel |
11 |
Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress
|
Yao, Hang-Ping |
|
|
26 |
8 |
p. 1857-1874 |
artikel |
12 |
Extrapolation: Experience gained from original biologics
|
Rojas-Chavarro, Luisa-Fernanda |
|
|
26 |
8 |
p. 2003-2013 |
artikel |
13 |
GLP-1 peptide analogs for targeting pancreatic beta cells
|
Alavi, Seyed Ebrahim |
|
|
26 |
8 |
p. 1936-1943 |
artikel |
14 |
Klotho: A possible mechanism of action of SGLT2 inhibitors preventing episodes of acute kidney injury and cardiorenal complications of diabetes
|
Kale, Ajinath |
|
|
26 |
8 |
p. 1963-1971 |
artikel |
15 |
Lipid/polymer-based nanocomplexes in nucleic acid delivery as cancer vaccines
|
Beg, Sarwar |
|
|
26 |
8 |
p. 1891-1903 |
artikel |
16 |
Mitochondrial dysfunction: A potential target for Alzheimer’s disease intervention and treatment
|
Ke, Jia |
|
|
26 |
8 |
p. 1991-2002 |
artikel |
17 |
Nanofibers as drug-delivery systems for antimicrobial peptides
|
Sousa, Maurício G.C. |
|
|
26 |
8 |
p. 2064-2074 |
artikel |
18 |
Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis
|
Shukla, Rahul |
|
|
26 |
8 |
p. 1972-1979 |
artikel |
19 |
Overcoming the protein corona in chitosan-based nanoparticles
|
Caprifico, Anna E. |
|
|
26 |
8 |
p. 1825-1840 |
artikel |
20 |
R&D efficiency of leading pharmaceutical companies – A 20-year analysis
|
Schuhmacher, Alexander |
|
|
26 |
8 |
p. 1784-1789 |
artikel |
21 |
Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors
|
Reddy, Shriya |
|
|
26 |
8 |
p. 1944-1952 |
artikel |
22 |
Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms
|
Aquino-Jarquin, Guillermo |
|
|
26 |
8 |
p. 2025-2035 |
artikel |
23 |
Recent progress on targeting leukemia stem cells
|
Ma, Xiang-Yu |
|
|
26 |
8 |
p. 1904-1913 |
artikel |
24 |
Regulatory status quo and prospects for biosurfactants in pharmaceutical applications
|
Ismail, Ruba |
|
|
26 |
8 |
p. 1929-1935 |
artikel |
25 |
RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis
|
Eisa-Beygi, Shahram |
|
|
26 |
8 |
p. 1790-1793 |
artikel |
26 |
Stimulus-responsive liposomes for biomedical applications
|
Antoniou, Antonia I. |
|
|
26 |
8 |
p. 1794-1824 |
artikel |
27 |
Strategies for maximizing photothermal conversion efficiency based on organic dyes
|
Weng, Xiao-Lu |
|
|
26 |
8 |
p. 2045-2052 |
artikel |
28 |
Sunitinib and its effect in the cardiovascular system
|
Mahdi, Ali |
|
|
26 |
8 |
p. 1773-1775 |
artikel |
29 |
Synthesis and modification of bio-derived antibacterial Ag and ZnO nanoparticles by plants, fungi, and bacteria
|
Alavi, Mehran |
|
|
26 |
8 |
p. 1953-1962 |
artikel |
30 |
Towards population-specific pharmacogenomics in the era of next-generation sequencing
|
Ji, Xiangjun |
|
|
26 |
8 |
p. 1776-1783 |
artikel |
31 |
Unravelling KDM4 histone demethylase inhibitors for cancer therapy
|
Baby, Stephin |
|
|
26 |
8 |
p. 1841-1856 |
artikel |
32 |
Using response surface models to analyze drug combinations
|
Twarog, Nathaniel R. |
|
|
26 |
8 |
p. 2014-2024 |
artikel |
33 |
Which factors matter the most? Revisiting and dissecting antibody therapeutic doses
|
Tang, Yu |
|
|
26 |
8 |
p. 1980-1990 |
artikel |